The Shenzhen Stock Exchange announced adjustments to the Hong Kong Stock Connect (港股通) eligible securities list, effective May 6, 2026. Koford Medical (01187) and Jingwei Tiandi (02477) will be added to the list. This adjustment is due to Koford Medical not having a price stabilization mechanism on the Hong Kong Stock Exchange and Jingwei Tiandi beginning parallel trading of split shares. Additionally, the Shanghai and Shenzhen stock exchanges reported a net decrease in margin trading balances, totaling 16.742 billion yuan. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This is a significant adjustment to a major financial market's trading eligibility list. [lever_c_demoted from significant: ic=1 ai=0.1]